Active Stocks

Fri Dec 12 2025 13:10:54

Tata Steel share price
171.30 2.98%

Eternal share price
296.65 1.91%

ICICI Bank share price
1,366.10 0.45%

ITC share price
400.70 -0.58%

Bharat Electronics share price
389.65 0.46%

Business News > Mint Authors > Peter Loftus

Peter Loftus

ARTICLES BY PETER LOFTUS

Powerful GLP-1 weight-loss drugs are changing Thanksgiving for users—and their friends and families celebrating with them. (AFP)

The Americans skipping Ozempic to indulge at Thanksgiving

4 min read . 26 Nov 2025

Whit Bernard, left, and Clive Meanwell Zé Otavio

This unlikely duo is developing a weight-loss pill. Big Pharma is obsessed.

6 min read . 07 Nov 2025

Health Secretary Robert F. Kennedy Jr. has made fighting obesity and accompanying chronic diseases one of the primary goals of his Make America Healthy Again agenda. (REUTERS)

Trump negotiating deal with Ozempic maker to sell weight-loss drugs for $149

3 min read . 05 Nov 2025

For years, weight loss was a graveyard for drug development and shunned by large drugmakers.

The day pharma’s weight-loss gold rush intensified

4 min read . 31 Oct 2025

Lilly says the supercomputer will run on 100% renewable electricity within existing company facilities.

Eli Lilly partners with Nvidia to build AI supercomputer for drug discovery

3 min read . 29 Oct 2025

Pfizer avoids US tariffs with a drug price deal, angering other pharma CEOs. The deal secures lower Medicaid prices and a direct-to-consumer platform, driven by a Trump-Bourla relationship. (Bloomberg)

Inside Pfizer’s drug-pricing deal with the Trump administration

8 min read . 03 Oct 2025

The Tylenol bottle says women who are pregnant should speak to a health professional before taking the medicine. (REUTERS)

Inside the crisis at Tylenol

10 min read . 27 Sept 2025

North Carolina Gov. Roy Cooper marked the opening of a new Eli Lilly plant in Concord, N.C., with company executives last year.

Drugmakers have pledged to invest $350 billion in US after tariff threat

3 min read . 17 Sept 2025

Moderna’s Covid vaccine went on to be used globally and has been credited with saving millions of lives.

How Moderna went From pandemic hero to vaccine victim

5 min read . 03 Jun 2025

Novo Nordisk loses dominance in the weight-loss drug market as Eli Lilly gains ground.

How Ozempic’s maker lost its grip on the obesity market it created

6 min read . 29 May 2025

GLP-1 drugs like Ozempic show widespread promise beyond weight loss/diabetes, but cost and supply limit broader adoption. (Image: AFP)

Should everyone be taking Ozempic? Doctors say more people could benefit.

5 min read . 26 May 2025

Moderna CEO Stéphane Bancel said the company doesn’t plan to transfer its proprietary mRNA technology to the Chinese. Photo: Adam Glanzman/Bloomberg News

Moderna is gambling on China as other US companies pull back

4 min read . 09 Jan 2025

The results could give Zepbound an edge over Wegovy in one of the fastest-growing prescription-drug markets. Photo: REUTERS

Eli Lilly’s Zepbound beats Novo Nordisk’s Wegovy in first head-to-head study

1 min read . 04 Dec 2024

To date, Zepbound has been packaged in a single device, an injection pen that contains both the drug and the needle.

Eli Lilly to sell new Zepbound option for about half price of injection pens

3 min read . 27 Aug 2024

The tests are performed on blood squeezed from a fingertip, rather than drawn from an arm’s vein. (WSJ)

The companies realizing Theranos’s failed dream

4 min read . 30 Jul 2024

Eli Lilly is the biggest drugmaker by market value thanks to the success of its diabetes and anti-obesity drugs. (Bloomberg)

Approval of newest Alzheimer’s drug will accelerate new era of treatment

1 min read . 03 Jul 2024

Eli Lilly will spend more than $5 billion to expand an Indiana manufacturing site and eventually make more doses of its hot-selling weight-loss and diabetes treatments, Zepbound and Mounjaro. (AP Photo)

Lilly’s weight-loss drug is a huge hit. Its CEO wants to replace it ASAP.

8 min read . 14 Jun 2024

(Illustration: WSJ, IStock)

Influencers love Ozempic—but they aren’t telling you about the risks

7 min read . 19 Apr 2024

The diabetes drug Ozempic is facing a surge in demand. PHOTO: F. MARTIN RAMIN/THE WALL STREET JOURNAL

Drug shortages in U.S. reach a record high

4 min read . 13 Apr 2024

The launch of Winrevair returns cardiovascular treatment to a prominent place at Merck. (Bloomberg)

Merck’s $11.5 billion bet on its next big drug finally arrives

2 min read . 27 Mar 2024